UNDERSTANDING THE PSYCHONAUT PERSPECTIVE ON CATHINONES

N-Ethylhexedrone was patented through the German pharmaceutical business Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis along with other derivatives of aminoketone.[one]N-Ethylhexedrone offers cross-tolerance with all noradrenergic and dopaminergic stimulants, which means that following the intake